Form CORRESP - Correspondence:
SEC Accession No. 0001493152-24-051958
Filing Date
2024-12-26
Accepted
2024-12-26 06:02:29
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 11917
2 formcorresp_001.jpg GRAPHIC 3105
  Complete submission text file 0001493152-24-051958.txt   17342
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)